Probiotics in Anticancer Immunity

Author(s): Prashant Shankar Giri and Mitesh Kumar Dwivedi * .

DOI: 10.2174/9789815124781123030008

Probiotics Based Anticancer Immunity in Colorectal Cancer

Pp: 119-142 (24)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Colorectal cancer (CRC) is the third most common cancer, originating in the colon and rectal region, leading to abnormal growth in the colon or rectal region. The gut microbiota plays a critical role in the maintenance of gut homeostasis, and dysbiosis in the gut microbiota has been associated with CRC pathogenesis. Probiotics can manipulate the gut microbiota, which can be effective in CRC treatment. Additionally, probiotics, through the modulation of host immune response, inhibition of tumor growth, reduction of microbial infection, inhibition of cancerogenic compounds, and regulation of apoptosis, can become a novel therapeutic option for the prevention and treatment of CRC. Therefore, this chapter mainly focuses on the mechanisms of probiotics-based anticancer immunity in CRC, so the existing knowledge could help in developing a safe and effective treatment for CRC.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books